XTX Topco’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$939K Sell
5,564
-9,728
-64% -$1.66M 0.02% 1470
2025
Q4
$2.58M Buy
15,292
+7,879
+106% +$1.28M 0.07% 413
2025
Q3
$1.07M Buy
7,413
+1,985
+37% +$271K 0.06% 541
2025
Q2
$687K Buy
5,428
+855
+19% +$105K 0.03% 894
2025
Q1
$585K Buy
4,573
+1,024
+29% +$139K 0.03% 913
2024
Q4
$469K Buy
+3,549
New +$499K 0.04% 814

Other funds holding IBB

XTX Topco's IBB Position: Q1 2026 in Review

XTX Topco reduced its iShares Biotechnology ETF (IBB) stake by 64% in Q1 2026, selling an estimated $1.66M and leaving 5,564 shares worth $939K. The position accounts for 0.02% of the portfolio, ranked #1470.

XTX Topco first reported a position in IBB in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.58M in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • XTX Topco held 5,564 shares of iShares Biotechnology ETF worth $939K as of Q1 2026.
  • XTX Topco sold 9,728 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.66M.
  • iShares Biotechnology ETF made up 0.02% of XTX Topco's portfolio in Q1 2026, its #1470 holding.
  • XTX Topco first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 6 quarters since.
  • XTX Topco's iShares Biotechnology ETF position peaked at $2.58M in Q4 2025.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.